January 18, 2025

Community Webinar: REGENXBIO AFFINITY DUCHENNE Pivotal Trial and Interim Functional Data

When:
January 23, 2025 1:00PM

Join Jett Foundation’s Community Webinar Series to hear from the team at REGENXBIO on their RGX-202: AFFINITY DUCHENNE Pivotal Trial and Interim Functional Data.

REGENXBIO: RGX-202 AFFINITY DUCHENNE
Thursday, January 23, 2025
1pm ET | 12pm CT | 11am MT | 10am PT

 

Jahannaz (Naz) Dastgir, D.O.

Guest Speaker

Jahannaz Dastgir, DO is a pediatric neuromuscular specialist and the clinical development lead of the RGX-202 program at REGENXBIO. This program focuses on AAV8 gene therapy for Duchenne muscular dystrophy.

Our Community Webinar Series is focused on ensuring that our Duchenne and rare disease community is better prepared for those unexpected moments, challenging medical decisions, and difficult stages when on a Duchenne journey.

No one ever expects Duchenne and there is no correct way to tackle a diagnosis, but we can always better prepare. This webinar series is an opportunity to equip yourself with more knowledge, resources, and tools for those real-life, often unanticipated, scenarios.

Experience the magic this summer!

How is the rare disease community accomplishing goals?

Tune in on February 29 to hear from our panel and moderators on how they are accomplishing goals and living life to the fullest!

Your gift helps Jett Foundation provide programming and opportunities, such as Camp Promise, to many families impacted by Duchenne muscular dystrophy each year.

Accessible Vehicle Fund Applications Open